BioCentury
ARTICLE | Finance

2009 milestones

January 12, 2009 8:00 AM UTC

Selected products with Phase III or regulatory milestones expected in 2009. (A) The long-acting release formulation of Byetta exenatide uses Medisorb drug delivery technology from Alkermes (NASDAQ:ALK...